In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use"
J Med Toxicol
.
2017 Jun;13(2):201.
doi: 10.1007/s13181-017-0613-9.
Epub 2017 Apr 5.
Authors
Cecilia J Sorensen
1
,
Kristen DeSanto
2
,
Laura Borgelt
3
,
Kristina T Phillips
4
,
Andrew A Monte
5
6
7
Affiliations
1
Denver Health Residency in Emergency Medicine, Denver Health and Hospital Authority, Denver, CO, 80204, USA. Cecilia.Sorensen@denverem.org.
2
Health Sciences Library, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
3
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
4
School of Psychological Sciences, University of Northern Colorado, Greeley, CO, USA.
5
Denver Health Residency in Emergency Medicine, Denver Health and Hospital Authority, Denver, CO, 80204, USA.
6
Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
7
Rocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
PMID:
28382464
PMCID:
PMC5440326
DOI:
10.1007/s13181-017-0613-9
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cannabinoids
Humans
Marijuana Abuse
Marijuana Smoking
Marijuana Use*
Nausea
Vomiting*
Substances
Cannabinoids
Grants and funding
K23 GM110516/GM/NIGMS NIH HHS/United States
UL1 TR001082/TR/NCATS NIH HHS/United States